Get Permission Bera, Pathak, Pathak, Maity, Paul, and Ghosh: Evaluation of biochemical markers for detection of chronic kidney diseases (CKD) in covid positive patient among hospitalize individuals


Introduction

Chronic kidney disease (CKD) is becoming a major public health problem worldwide. The current burden of disease might due to a change of the underlying pathogenicity of CKD. Glomerulonephritis was the one of the leading causes of kidney disease several decades ago. In India, given its population >1 billion, the rising incidence of CKD is likely to pose major problems for both healthcare and the economy in future years. Indeed, it has been recently estimated that the age-adjusted incidence rate of ESRD in India to be 229 per million population (pmp),1 and >100,000 new patients enter renal replacement programs annually in India. 2

Worldwide, the prevalence of CKD varies from eight to 16 per cent representing over 750 million cases, of which 78 per cent (387.5 million) are from low-middle-income countries (LMICs).3, 4 The development and outcomes of CKD are impacted by local factors like aetiological spectrum influenced by local risk factors, genetic differences, socio-demographic variables and access to healthcare resources. Cohort studies in patients with CKD have been established in the USA, Germany, Canada, France, Spain, Japan, Republic of South Korea and China.5, 6, 7, 8, 9, 10, 11 The Screening and Early Evaluation of Kidney Disease by estimation of biochemical markers was designed and performed to generate data to determine the prevalence and risk factors for CKD in future diagnostic purpose.

Materials and Methods

The current study was carried out in the department of pathology, salboni super speciality hospital, WB, India from June2020 to Nov2020 among 50 hospitalized covid positive individuals previously suffering from CKD, also taking dialysis repeatedly. Through venipuncture blood sample were collected and serum is separated from blood sample. Detection of chemical markers like erythropoietin level, cystatin C (CysC), beta trace protein, IL- 6, IL- 8 and TNF alpha level was performed by CLIA(b technique. The study was approved by ethics committee.

Results

Total 50 samples were collected from ICU and Non-ICU individuals during six month study period of covid pandemic situation (June 2020 to Nov 2020). We studied different bio-chemical in three different age group of CKD patient. We observed very significant value of erythropoietin in age group between 30-39 in female patient and in age group of both 40-49 and 50-59 in male patient. Similarly cystatin-C level was significantly identified in all age group. In case of Beta trace protein we showed more significant result in male among all age group than female. Very significant result seen in immunological parameters in IL-6 and IL-8 value in all age for both male and female patient than TNF-alpha value.

Table 1

Age Group (yrs.)

Erythropoietin level

(mu/ml)

Cystatin C (mg/L)

Beta trace protein

(mg/L)

IL-6 (pg/ml)

IL-8 (pg/ml)

TNF-alpha (pg/ml)

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

30-39

2.80 ± 0.830NS

1.20 ± 0.274 *

8.11 ± 1.118 *

8.41 ± 1.185 *

1.04 ± 0.176 *

1.43 ± 0.294*

42.59 ± 3.442 *

46.02 ± 1.758 *

17.92 ± 1.484 *

20.71 ± 2.045 *

87.06 ± 4.284 *

86.52 ± 5.094 *

40-49

1.84 ± 0.373 *

1.93 ± 0.687NS

8.60 ± 0.659 *

9.00 ± 0.596 *

1.65 ± 1.117NS

1.17 ± 0.131 *

42.95 ± 2.216 *

43.63 ± 3.084 *

21.05 ± 1.087 *

21.41 ± 1.489 *

90.24 ± 2.580 *

91.32 ± 3.564 *

50-59

1.41 ± 0.156 *

3.28 ± 1.115NS

9.51 ± 0.326 *

7.78 ± 0.545 *

1.09 ± 0.139 *

1.43 ± 0.187 *

45.15 ± 7.459 *

41.86 ± 2.430 *

22.44 ± 0.544 *

19.58 ± 2.054 *

96.28 ± 5.852 *

95.92 ± 5.974 *

Figure 1

Percentage of Biochemical parameters.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/d39282c7-76ab-4f43-a7d3-d13dd94d4761image1.png
Figure 2

Graphical presentation of significant biochemical markers in female patient.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/d39282c7-76ab-4f43-a7d3-d13dd94d4761image2.png
Figure 3

Graphical presentation of significant biochemical markers in male patient.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/d39282c7-76ab-4f43-a7d3-d13dd94d4761image3.png

Discussion

This systematic review the prevalence of CKD in various population-based studies, which used a standardized definition of CKD and considered age-, gender and ethnic-specific prevalence of CKD. Overall, the prevalence of CKD varied widely among the study populations and increased clearly with age. In general, females had a higher prevalence than males, especially in the middle aged groups. Our results confirmed that 18% decreasing rate of EPO level, 84% increasing level of Cystatin C, BTP level showed 90% increasing rate, IL-6 increasing 62% rate, IL-8 showed 78% increasing rate and finally TNF-alpha increasing 52% from total testing parameter.

Erythropoietic level

Erythropoietic level significantly increases for female in age group (30-39) in respect to normal range. For female in age group (40-49) and age group (50-59) is significantly decrease when compared to reference values (Table 1 ). For male age group (30-39) is significantly decrease but age group (40-49) and age group (50-59) is significantly increase in respect to reference values (Figure 1). Similarly the study was done by Beverborg et al., 12 2015 in University Medical Center Groningen, they were found EPO levels to increase over age and they also found that the association hemoglobin with EPO levels in healthy subjects, especially in anemic conditions, is strongly dependent on renal function.

Cystatin C

Level of Cystatin-C in all the groups was significantly similar. Cystatin C level significantly increased in age group (30-39), age group (40-49) and age group (50-59) for female in respect to reference range (Table 1). In case of male age group (30-39), age group (40-49) and age group (50-59) is significantly increase when compared to reference values (Figure 1). As compare the study was done by Peralta et al., 13 2011 in California, they isolate that the prevalence of decrease GFR on the basis of cystatin C only was relatively low in the diverse cohort of ambulatory subjects, particularly in the nonelderly. The number needed to screen to detect such individuals was high overall but decreased to about 10 among persons over the age of 75.

Beta trace protein

In my current study Beta trace protein level significantly increased in age group (30-39), age group (40-49) and age group (50-59) for female in respect of normal range (Table 1). For male age group (40-49) is significantly decrease but age group (30-39) and age group (50-59) is significantly increase in respect to reference values (Figure 1). Simillarly the study was done by Dajak et al., 14 2011 in Serbia, they find out that urinary BTP concentrations in patients with albuminuria below 30 mg/day were significantly lower than in patients with albuminuria above 30 mg/day (p < 0.0001).

IL-6

Interleukin-6 level in all the groups were significantly similar. IL 6 level significantly increased in age group (30-39), age group (40-49) and age group (50-59) for female in respect to reference range (Figure 2). In case of male age group (30-39), age group (40-49) and age group (50-59) is significantly increase when compared to reference values (Figure 3). Similarly the study was done by Lee et al.,15 2015 in USA, they isolate that IL-6 is independently and significantly associated with lower eGFR and higher albuminuria.

IL-8

Both male or female age groups IL-8 level were significantly closer. In female IL-8 level is significantly increased in respect of reference range in three age groups (Figure 2). In case of male age group (30-39), age group (40-49) and age group (50-59) is significantly increased in respect to reference values (Figure 3).Similarly the study was done by Tunçay et al.,16 2021 in Turkey, they find out that the serum IL-8 levels of CKD were significantly higher than of healthy subjects, respectively (p<0.001). There was no statistically significant difference between IL-8 in CKD patients with and without cardiovascular disease (p>0.05).

TNF alpha

TNF alpha level significantly increased in age group (30-39), age group (40-49) and age group (50-59) for female in respect to reference range (Figure 2). In case of male age group (30-39), age group (40-49) and age group (50-59) is significantly increase when compared to reference values (Figure 3). Similarly, the study was done by Sonkar et al., 17 2009 in Varanasi, they find out that the TNF alpha levels are significantly higher levels in CKD and renal transplant patients.

Current study significantly showed different parameters of chemical secretion of covid positive CKD patient. IL-6 and IL-8 and increasing parameters may be seen due to hypersensitivity reaction for viral transmission of body. Other immunological parameters can be increase for exposure of viral element significantly.

Conclusion

Different hematological and immunological markers of kidney disease have an affinity to be classified by a few common limitations. In CKD patient already are immunocompromise patient and as well as due to changes of GFR, chemical regulation may hampered inside the body and changes of immunological parameters due to covid infection, causes secretion of interlukins and TNF for activation of hypersensitivity and complement system inside body. In present study, can be helpful for future diagnostic purpose in immune-haemato parameters in immunocompromise patient in different aspect.

Conflict of Interest

The authors declare no relevant conflicts of interest.

Source of Funding

None.

References

1 

G K Modi V Jha The incidence of end-stage renal disease in India: a population-based studyKidney Int200670122131310.1038/sj.ki.5001958

2 

V Kher End-stage renal disease in developing countriesKidney Int20026213506210.1046/j.1523-1755.2002.00426.x

3 

D C Crews A K Bello G Saadi World Kidney Day Steering Committee. Burden, access, and disparities in kidney diseaseNephron2019141219910.1159/000495557

4 

C George A Mogueo I Okpechi J B Echouffo-Tcheugui A P Kengne Chronic kidney disease in low-income to middleincome countries: The case for increased screeningBMJ Glob Health201722e00025610.1136/bmjgh-2016-000256

5 

JP Lash AS Go LJ Appel J He A Ojo M Rahman Chronic Renal Insufficiency Cohort (CRIC) Study Group. Chronic Renal Insufficiency Cohort (CRIC) study: baseline characteristics and associations with kidney functionClin J Am Soc Nephrol200948130211 10.2215/CJN.00070109

6 

E Imai S Matsuo H Makino T Watanabe T Akizawa K Nitta Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal functionClin Exp Nephrol20101465587010.1007/s10157-010-0328-6

7 

A Levin C Rigatto B Brendan F Madore N Muirhead D Holmes Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT)BMC Nephrol20131412110.1186/1471-2369-14-121

8 

D Arroyo A Betriu M Martinez-Alonso T Vidal JM Valdivielso E Fernández Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA studyBMC Nephrol20141516810.1186/1471-2369-15-168

9 

B Stengel C Combe C Jacquelinet S Briançon D Fouque M Laville The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort studyNephrol Dial Transplant20142981500710.1093/ndt/gft388

10 

E Kang M Han H Kim S Kyung Park J Lee YY Hyun Baseline general characteristics of the Korean chronic kidney disease: report from the Korean cohort study for outcomes in patients with chronic kidney disease (KNOW-CKD)J Korean Med Sci201732222130 10.3346/jkms.2017.32.2.221

11 

J Yuan X R Zou S P Han H Cheng L Wang JW Wang on behalf of the C-STRIDE Study Group. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)BMC Nephrol20171812310.1186/s12882-017-0441-9

12 

NG Beverborg N Verweij IT Klip HH Van Der Wal AA Voors DJ Van Veldhuisen Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic CorrelatesPols One2015104e012521510.1371/journal.pone.0125215

13 

CA Peralta R Katz MJ Sarnak I Joachim LF Fried ID Boer Cystanin C Identifies Chronic Kidney Disease Patients at Higher Risk for ComplicationsJ Am Soc Nephrol20112211475510.1681/ASN.2010050483

14 

M Dajak S Ignjatović B Stojimirović S Gajić N Majkić-Singh Evolution of renal damage by urinary beta trace protein in patients with chronic kidney diseasesClin Lab2011571-22936

15 

B T Lee F A Ahmed L L Hamm F J Teran C S Chen Y Liu Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney diseaseBMC Nephrol2015167710.1186/s12882-015-0068-7

16 

SC Tunçay E Doğan G Hakverdi JÜ Tutar S Mir Interleukin-8 is increased in chronic kidney disease in children, but not related to cardiovascular diseaseJ Bras Nefrol202143335964

17 

GK Sonkar Usha RG Singh Evaluation of serum tumor necrosis factor alpha and its correlation with histology in chronic kidney disease, stable renal transplant and rejection casesSaudi J Kidney Dis Transpl200920610004



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 18-07-2022

Accepted : 28-07-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmmtd.2022.048


Article Metrics






Article Access statistics

Viewed: 546

PDF Downloaded: 151



Medical Abbreviation List